Fortress Biotech

Fortress Biotech is an innovative biopharmaceutical company focused on acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. The company has eight marketed prescription drug products and over 30 development projects across Fortress, its majority-owned and majority-controlled partners and subsidiaries, as well as its founded partners and subsidiaries, in which the company holds significant minority stakes. These product candidates span six major therapeutic areas, including oncology, rare diseases, and gene therapy, creating value for shareholders. Fortress advances its diversified pipeline through a streamlined operational structure to facilitate efficient drug development. The Fortress model is driven by a world-class business development team that leverages its extensive biopharmaceutical industry expertise to further expand the company’s portfolio of opportunities. Fortress has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize the potential of every opportunity.